This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Srdjan R Stankovic: Innovator in Alzheimer's Disease Treatment
Introduction
Srdjan R Stankovic is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease psychosis. His innovative approach has led to the development of a patent that addresses critical symptoms associated with dementia.
Latest Patents
Stankovic holds a patent for "Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis." This patent outlines methods for treating Alzheimer's disease psychosis, including the administration of pimavanserin. The patent also details methods for treating delusions and hallucinations in individuals with dementia, as well as reducing agitated or aggressive behavior in these patients. His work aims to improve the quality of life for those suffering from Alzheimer's disease.
Career Highlights
Srdjan R Stankovic is associated with Acadia Pharmaceuticals Inc., a company dedicated to developing innovative treatments for central nervous system disorders. His role at Acadia has allowed him to focus on groundbreaking research and development in the field of neuropsychiatry.
Collaborations
Stankovic has collaborated with esteemed colleagues, including Bruce Duane Coate and James Randall Owen. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Srdjan R Stankovic's contributions to the treatment of Alzheimer's disease psychosis through his innovative patent demonstrate his commitment to improving patient care. His work at Acadia Pharmaceuticals Inc. and collaborations with other professionals highlight the importance of teamwork in advancing medical research.